Document is current
Any future updates will be listed below
-
Authors
Xue, Song
Kraus, Sabrina
Enke, Johanna S.
Michalski, Kerstin
Hacker, Marcus
Einsele, Hermann
Buck, Andreas K.
Lapa, Constantin
Li, Xiang https://orcid.org/0000-0002-0016-6233
Dreher, Niklas
-
Funding
Funding for this research was provided by:
Medical University of Vienna
- License Information
-
More Information
Article History
Received: 12 December 2025
Accepted: 2 February 2026
First Online: 18 February 2026
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. CXCR4-directed RPT was conducted on an individual basis according to the German Pharmaceutical Act (ยงย 13.2b). The need for an approval for this analysis was waived by the local ethics committee due to the retrospective nature of this study (# 20220103 01).
: Informed consent was obtained from all individual participants included in the study.
: All authors have read this manuscript and would like to have it considered exclusively for publication.
: AKB: involved in [68Ga]Ga-Pentixafor PET imaging in marginal zone lymphoma (LYMFOR) and has previously received speakers honoraria from PentixaPharm. AKB is a member of the advisory board of PentixaPharm. M.H. is an editor of EJNMMI.
